Just out @NEJM from @DhruvKhullar et al. The structure of rewards (and costs) in pharmaceutical drug development. We introduce the 'reward box' interactive graphic to see how the elements interplay, how specific policies affect it.https://www.nejm.org/doi/full/10.1056/NEJMhpr1911004?query=featured_home …
-
-
Graphic labeled the 'Reward Box' to enable the double entendre sub-header in the title. But also, we want policymakers to in fact 'think inside the box'. The market is a policy construct, it is not 'free'. The industry sees it all of a piece, policy makers should too.
Show this threadThanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.